Report Categories
View AllRecent Articles
View All
SABS shares surge 76 despite SAB Biotherapeutics deeperthanexpected quarterly loss investors bullish on pipeline prospects
Generate Biomedicines GENB vs Competition GENB Latest Quarter Earnings Generate Biomedicines posts AI drug pipeline wins
USBC USBC delivers narrower than expected Q1 2025 per share loss stock climbs nearly two percent today
ARWR Arrowhead Q1 earnings beat estimates with massive revenue surge yet shares slip 15 despite strong results
NXG NXG upcoming quarterly earnings release will outline key strategic priorities for its core infrastructure portfolio
AES Corporation XLU Shifting Analyst Sentiment and Sector Headwinds Shape NearTerm Outlook
The real value proposition of GCL Global GCL stock 260 20260508
NetEase Inc NTES Unusual Options Activity Signals Elevated Expected Volatility Amid Neutral Fundamental Outlook
ALCO Alico reports wider than expected Q1 2026 per share loss even as shares edge higher in daily trading
GNLN Greenlane Holdings posts far wider Q2 2023 loss than forecasts shares drop 10 percent on investor concern